Pharmaceutical 7071 articles

J&J stocks tumble in wake of scathing Reuters report

Johnson & Johnson’s stock prices fell more than 10 percent – from $147 per share to $130 – after Reuters reported that an examination of the company’s internal documents revealed that J&J’s talcum powder was contaminated with cancer-causing asbestos and that the company took measures to hide this information from regulators and the public. The consumer health care giant, facing more 11,000 lawsuits alleging its talc-containing products have caused cancers like mesothelioma and ovarian cancer, has continuously defended the safety of its products. And while J&J has won some of the cases, its losses have been substantial, including a $4.69 ... Read More

J&J knew for decades its talc contained asbestos

Nearly 20 years ago, Darlene Coker sued Johnson & Johnson. She had been diagnosed with mesothelioma, a rare but deadly form of cancer that is caused by asbestos exposure. How could the 52-year-old who ran a massage school in eastern Texas while raising two daughters develop the disease? It must have been the Johnson’s Baby Powder she regularly dusted on her children and herself. Talc, like asbestos, is mined from the earth. To her and her attorney, it wasn’t too far a leap to suggest J&J’s talc-containing product could have contained asbestos and caused her deadly disease. Coker sought to ... Read More

Mylan expands blood pressure drug recall

Mylan Pharmaceuticals is expanding its recall of high blood pressure and heart failure treatments to include all its products that contain the active ingredient valsartan because they may contain trace amounts of a potentially cancer-causing impurity. The 104 additional lots involved in the recall include varying doses of 26 lots of amlodipine and valsartan tablets, 51 lots of valsartan tablets, and 27 lots of valsartan and hydrochlorothiazide tablets. The tablets were distributed nationwide from March 2017 to November 2018. A list of affected drugs can be found on Mylan’s recall notice. The impurity found in the drugs is N-nitrosodiethylamine (NDEA), ... Read More

Canada assessment finds ‘Talc may be harmful to human health’

Government officials in Canada are considering prohibiting or restricting the use of talc in certain cosmetics and other products after an assessment of the mineral by Health Canada and Environment and Climate Change Canada raised concerns about its risks to public health and the environment. “Most uses of talc (such as in paper, plastics, paint, ceramics, putties, food, as well as many cosmetics, natural health products and non-prescription drugs) are not a concern to human health,” Health Canada said. “However, based on the latest science and the draft screening assessment, the Government of Canada proposes that inhaling loose talc powders ... Read More

Significant health issues linked to Rhino-branded ED supplements

A rise in reported health issues linked to various Rhino-branded male enhancement supplements has prompted the Food and Drug Administration (FDA) to issue a warning to consumers that the products should not be purchased or used because they contain hidden drugs that can be dangerous to consumers’ health. The FDA has received reports of people experiencing chest pain, severe headaches and prolonged erections after taking a Rhino product that led to surgical intervention and hospitalization due to extreme drops in blood pressure. Since 2007, the FDA has identified more than 25 products marketed with variations of the name “Rhino” that ... Read More

Opioid Rx from dentist may increase abuse risk in youth

Young people who are given opioids to treat pain following a dental procedure have a higher risk of risk of refilling the prescription within a year, and those who do are at greater risk of becoming addicted to the drugs, according to a study published in JAMA Internal Medicine. The study, conducted by researchers with Stanford University, involved a sampling of youth who had not taken opioids prior to visiting the dentist. About 6.9 percent who had received a prescription for opioids filled at least one additional prescription between three months and one year after they were first prescribed the ... Read More

China, US reach agreement over fentanyl

In an effort to curb the deadly opioid epidemic that killed more than 49,000 in the United States last year, President Donald Trump struck a deal with China’s President Xi over regulation of the powerful synthetic opioid fentanyl during a scheduled dinner between the two leaders at the G-20 summit. “Very importantly, President Xi, in a wonderful humanitarian gesture, has agreed to designate fentanyl as a controlled substance, meaning that people selling fentanyl to the United States will be subject to China’s maximum penalty under the law,” White House Press Secretary Sarah Sanders said in a statement. The statement issued ... Read More

Increases in overdoses, suicide drive down life expectancy again

New statistics showing a downtick in U.S. life expectancy for the second time in three years is a “wake up call,” the Centers for Disease Control and Prevention said, with many causes of death being preventable, namely drug overdoses and suicide. “Life expectancy gives us a snapshot of the Nation’s overall health,” said CDC Director Robert Redfield, adding the latest numbers are “sobering.” The drop in overall life expectancy averaged 78.6 years in 2017, a 0.1 decrease from the year before. Redfield said the reason was due to the rise in overdoses and suicides. Opioids are especially deadly. More than ... Read More

MS drug linked to serious strokes, tears in arteries

Reports of rare but serious strokes and tears in the lining of the arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after starting treatment with the drug Lemtrada (alemtuzumab), which can lead to permanent disability and even death, the Food and Drug Administration (FDA) warned in a Safety Communication. The drug ingredient alemtuzumab was initially approved in 2001 under the brand name Campath to treat a type of cancer called B-cell chronic lymphocytic leukemia, or B-CLL. In 2014, the drug was approved under the brand name Lemtrada to treat relapsing forms of MS. ... Read More

FDA warns companies for marketing ‘unlawful’ supplements for opioid withdrawal

The Food and Drug Administration (FDA) warned two companies for illegally selling dietary supplements that contain the unapproved antidepressant tianeptine, and for making “unproven and unlawful” claims that the products can treat opioid withdrawal symptoms, pain and anxiety. Jack B Goods Outlet Store was warned about its Tianaa Red, Tianaa White and Tianaa Green supplements. MA Labs was warned for its Vicaine supplement. The supplements pose risks to consumers for a variety of reasons. Tianeptine is not approved in the United States or the United Kingdom, as well as other countries, because it can induce euphoria and carries a risk ... Read More